Kato, M
Serretti, A
Nonen, S
Takekita, Y http://orcid.org/0000-0003-2435-4033
Wakeno, M
Azuma, J
Kinoshita, T
Article History
Received: 19 December 2014
Revised: 19 December 2014
Accepted: 24 December 2014
First Online: 24 February 2015
Competing interests
: This study was supported by grants from SENSHIN Medical Research Foundation and Grant-in-Aid for Scientific Research (KAKENHI). GlaxoSmithKline, Asahi Kasei Pharma Corporation and Meiji Seika Kaisha Ltd determined plasma level of paroxetine milnacipran and fluvoxamine and provided no further support. The authors declare no conflict of interest.